IRIDEX Corporation Cash Flow Conversion Efficiency
IRIDEX Corporation cash flow conversion efficiency. Based on the latest financial reports, IRIDEX Corporation (IRIX) has a cash flow conversion efficiency ratio of 0.048x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($174.00K) by net assets ($3.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of IRIDEX Corporation (1995–2025)
Cash flow conversion efficiency of IRIDEX Corporation from 1995 to 2025. This chart illustrates how IRIDEX Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IRIX stock price and chart for real-time trading data and today's change.
IRIDEX Corporation Cash Flow Conversion Ratio Explained
IRIDEX Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
IRIDEX Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IRIDEX Corporation ranked by their cash flow conversion efficiency. Also see IRIX market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Value8 N.V
AS:PREVA
|
0.000x |
|
Silver Ridge Holdings Bhd
KLSE:0129
|
-0.052x |
|
SOLWERS OYJ EO 1
F:0ST
|
N/A |
|
Just Group plc
LSE:JUST
|
0.765x |
|
Caravelle International Group
NASDAQ:HTCO
|
0.505x |
|
Fingerprint Cards AB (publ)
ST:FING-B
|
-0.007x |
|
Argenica Therapeutics Ltd
AU:AGN
|
-1.602x |
|
Western Resources Corp
TO:WRX
|
-0.001x |
Annual Cash Flow Conversion Efficiency for IRIDEX Corporation (1995–2025)
The table below shows the annual cash flow conversion efficiency of IRIDEX Corporation from 1995 to 2025. Review IRIDEX Corporation (IRIX) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.92 Million | $-2.12 Million | -0.430x | +87.63% |
| 2024-12-31 | $2.10 Million | $-7.29 Million | -3.474x | -390.43% |
| 2023-12-31 | $9.52 Million | $-6.75 Million | -0.708x | -28.23% |
| 2022-12-31 | $17.23 Million | $-9.52 Million | -0.552x | -256.64% |
| 2021-12-31 | $23.30 Million | $8.22 Million | 0.353x | +289.21% |
| 2020-12-31 | $17.37 Million | $-3.24 Million | -0.186x | +46.52% |
| 2019-12-31 | $22.70 Million | $-7.91 Million | -0.349x | -4.16% |
| 2018-12-31 | $29.96 Million | $-10.03 Million | -0.335x | -186.47% |
| 2017-12-31 | $30.52 Million | $-3.56 Million | -0.117x | -3076.34% |
| 2016-12-31 | $39.16 Million | $-144.00K | -0.004x | +79.11% |
| 2015-12-31 | $33.69 Million | $-593.00K | -0.018x | -114.79% |
| 2014-12-31 | $33.74 Million | $4.01 Million | 0.119x | +301.07% |
| 2013-12-31 | $25.85 Million | $767.00K | 0.030x | +246.69% |
| 2012-12-31 | $21.91 Million | $-443.00K | -0.020x | -114.88% |
| 2011-12-31 | $22.43 Million | $3.05 Million | 0.136x | -24.10% |
| 2010-12-31 | $19.43 Million | $3.48 Million | 0.179x | -60.42% |
| 2009-12-31 | $15.03 Million | $6.80 Million | 0.452x | +5635.50% |
| 2008-12-31 | $11.75 Million | $-96.00K | -0.008x | +70.55% |
| 2007-12-31 | $18.81 Million | $-522.00K | -0.028x | +35.57% |
| 2006-12-31 | $32.16 Million | $-1.39 Million | -0.043x | -153.67% |
| 2005-12-31 | $34.52 Million | $2.77 Million | 0.080x | +230.82% |
| 2004-12-31 | $31.78 Million | $771.00K | 0.024x | -85.34% |
| 2003-12-31 | $30.83 Million | $5.10 Million | 0.165x | +98.40% |
| 2002-12-31 | $30.20 Million | $2.52 Million | 0.083x | +168.46% |
| 2001-12-31 | $29.83 Million | $-3.63 Million | -0.122x | -4921.99% |
| 2000-12-31 | $30.50 Million | $-74.00K | -0.002x | -102.33% |
| 1999-12-31 | $27.50 Million | $2.86 Million | 0.104x | +234.75% |
| 1998-12-31 | $25.90 Million | $-2.00 Million | -0.077x | -1745.56% |
| 1997-12-31 | $23.90 Million | $-100.00K | -0.004x | +93.08% |
| 1996-12-31 | $21.50 Million | $-1.30 Million | -0.060x | -131.58% |
| 1995-12-31 | $4.70 Million | $900.00K | 0.191x | -- |
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more